Cellromax Science Co., Ltd. (KOSDAQ:471820)
South Korea · Delayed Price · Currency is KRW 4,110.00
-25.00 (-0.60%)
At close: Aug 11, 2026
Cellromax Science Market Cap
Cellromax Science has a market cap or net worth of 45.38 billion as of August 11, 2026. Its market cap has decreased by -27.64% in one year.
Market Cap
45.38B
Enterprise Value
36.50B
Revenue
20.98B
Ranking
n/a
PE Ratio
13.60
Stock Price
4,110.00
ChartMarket Cap Chart
Since December 13, 2024, Cellromax Science's market cap has decreased from 92.69B to 45.38B, a decrease of -51.04%. That is a compound annual growth rate of -34.96%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2026 | 45.38B | -38.32% |
| Dec 30, 2025 | 73.57B | 28.56% |
| Dec 30, 2024 | 57.23B | -38.25% |
| Dec 13, 2024 | 92.69B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| GFI Co., Ltd. | 84.20B |
| Black Yak I&C Co.,Ltd | 73.89B |
| NBR Motion | 63.05B |
| ERCOHS Agricultural Corporation Co.,Ltd | 54.69B |
| ALT Co., Ltd. | 43.12B |
| GITSN | 36.73B |
| Laseroptek | 35.03B |
| Korea No.14 Special Purpose Acquisition | 33.10B |